Regulatory Pathways for New Indications - Jaime Raben

↳ This is a section part of Moment: CRT 2017 : FDA VALVE - Percutaenous Aortic Valves: Knowledge Gaps in a Maturing Technology

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

 Regulatory Pathways for New Indications - Jaime Raben at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

Other Components in this Moment

Overview
Beyond Strategy Trials: Are We Ready for OPCs? - Michael Reardon
Update to Valve Durability and Leaflet Thrombosis - Raj Makkar
Regulatory Pathways for New Indications - Jaime Raben
Extending the Boundaries of TAVR: Future Directions - Michael Mack
Loading Simple Education